Immunity Pharma Ltd.   Report issue

For profit Phase 2
Founded: Mevaseret Zion Israel (2007)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03652805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Immunity Pharma Ltd.